Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20547452rdf:typepubmed:Citationlld:pubmed
pubmed-article:20547452lifeskim:mentionsumls-concept:C0033607lld:lifeskim
pubmed-article:20547452lifeskim:mentionsumls-concept:C0917721lld:lifeskim
pubmed-article:20547452lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:20547452lifeskim:mentionsumls-concept:C0439098lld:lifeskim
pubmed-article:20547452pubmed:issue14lld:pubmed
pubmed-article:20547452pubmed:dateCreated2010-7-8lld:pubmed
pubmed-article:20547452pubmed:abstractTextA series of HIV-1 protease inhibitors containing an epsilon substituted lysinol backbone was synthesized. Two novel synthetic routes using N-boc-L-glutamic acid alpha-benzyl ester and 2,6-diaminopimelic acid were developed. Incorporation of this epsilon substituent enabled access to the S2 pocket of the enzyme, affording high potency inhibitors. Modeling studies and synthetic efforts suggest the potency increase is due to both conformational bias and van der Waals interactions with the S2 pocket.lld:pubmed
pubmed-article:20547452pubmed:languageenglld:pubmed
pubmed-article:20547452pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20547452pubmed:citationSubsetIMlld:pubmed
pubmed-article:20547452pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20547452pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20547452pubmed:statusMEDLINElld:pubmed
pubmed-article:20547452pubmed:monthJullld:pubmed
pubmed-article:20547452pubmed:issn1464-3405lld:pubmed
pubmed-article:20547452pubmed:authorpubmed-author:WilliamsThere...lld:pubmed
pubmed-article:20547452pubmed:authorpubmed-author:SanchezRosa...lld:pubmed
pubmed-article:20547452pubmed:authorpubmed-author:HollowayM...lld:pubmed
pubmed-article:20547452pubmed:authorpubmed-author:CarrollSteven...lld:pubmed
pubmed-article:20547452pubmed:authorpubmed-author:VaccaJoseph...lld:pubmed
pubmed-article:20547452pubmed:authorpubmed-author:CoburnCraig...lld:pubmed
pubmed-article:20547452pubmed:authorpubmed-author:BurleinChrist...lld:pubmed
pubmed-article:20547452pubmed:authorpubmed-author:JonesKristen...lld:pubmed
pubmed-article:20547452pubmed:authorpubmed-author:SuHua-PooHPlld:pubmed
pubmed-article:20547452pubmed:authorpubmed-author:DiStefanoDani...lld:pubmed
pubmed-article:20547452pubmed:authorpubmed-author:TouchSinoeunSlld:pubmed
pubmed-article:20547452pubmed:copyrightInfo2010 Elsevier Ltd. All rights reserved.lld:pubmed
pubmed-article:20547452pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20547452pubmed:day15lld:pubmed
pubmed-article:20547452pubmed:volume20lld:pubmed
pubmed-article:20547452pubmed:ownerNLMlld:pubmed
pubmed-article:20547452pubmed:authorsCompleteYlld:pubmed
pubmed-article:20547452pubmed:pagination4065-8lld:pubmed
pubmed-article:20547452pubmed:meshHeadingpubmed-meshheading:20547452...lld:pubmed
pubmed-article:20547452pubmed:meshHeadingpubmed-meshheading:20547452...lld:pubmed
pubmed-article:20547452pubmed:meshHeadingpubmed-meshheading:20547452...lld:pubmed
pubmed-article:20547452pubmed:meshHeadingpubmed-meshheading:20547452...lld:pubmed
pubmed-article:20547452pubmed:year2010lld:pubmed
pubmed-article:20547452pubmed:articleTitleEpsilon substituted lysinol derivatives as HIV-1 protease inhibitors.lld:pubmed
pubmed-article:20547452pubmed:affiliationDepartment of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, West Point, PA 19486, USA. kristen_jones@merck.comlld:pubmed
pubmed-article:20547452pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:20547452lld:chembl